Literature DB >> 27721244

Helicobacter pylori infection and colorectal carcinoma risk: A meta-analysis.

Yang Zhao1, Xuli Wang2, Yanrong Wang3.   

Abstract

OBJECTIVE: Helicobacter pylori infection and colorectal cancer risk are not clear. We perform this meta-analysis to further evaluate the association between H. pylori infection and colorectal cancer susceptibility.
METHODS: The databases of CNKI, Wanfang, PubMed, Medline, EMBASE, and HighWire Press were electronic searched by two reviewers independently. The case-control study or cohort study about H. pylori infection and colorectal cancer risk were included in this meta-analysis. The association between H. pylori infection and colorectal cancer risk was evaluated by odds ratio (OR) and corresponding 95% confidence interval (95% CI).
RESULTS: Fourteen case-control studies related to H. pylori infection and colorectal cancer risk were eventually include in this meta-analysis. The pooled results showed that H. pylori infection slight increase the risk of developing colorectal carcinoma (OR = 1.33, 95% CI: 1.01-1.77, P = 0.05). Moreover, Begg's funnel plot demonstrated no significant publication bias.
CONCLUSION: Colorectal carcinoma is associated with H. pylori infection. However, for significant heterogeneity across the studies, this results should be further confirmed by large sample size cohort study.

Entities:  

Mesh:

Year:  2016        PMID: 27721244     DOI: 10.4103/0973-1482.191621

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN: 1998-4138            Impact factor:   1.805


  7 in total

1.  Serologic Response to Helicobacter pylori Proteins Associated With Risk of Colorectal Cancer Among Diverse Populations in the United States.

Authors:  Julia Butt; Matthew G Varga; William J Blot; Lauren Teras; Kala Visvanathan; Loïc Le Marchand; Christopher Haiman; Yu Chen; Ying Bao; Howard D Sesso; Sylvia Wassertheil-Smoller; Gloria Y F Ho; Lesley E Tinker; Richard M Peek; John D Potter; Timothy L Cover; Laura H Hendrix; Li-Ching Huang; Terry Hyslop; Caroline Um; Francine Grodstein; Mingyang Song; Anne Zeleniuch-Jacquotte; Sonja Berndt; Allan Hildesheim; Tim Waterboer; Michael Pawlita; Meira Epplein
Journal:  Gastroenterology       Date:  2018-10-06       Impact factor: 22.682

Review 2.  Role of Helicobacter pylori infection in the manifestation of old age-related diseases.

Authors:  Abolfazl Zendehdel; Maryam Roham
Journal:  Mol Genet Genomic Med       Date:  2020-02-17       Impact factor: 2.183

3.  Association of Combined Sero-Positivity to Helicobacter pylori and Streptococcus gallolyticus with Risk of Colorectal Cancer.

Authors:  Meira Epplein; Loïc Le Marchand; Timothy L Cover; Mingyang Song; William J Blot; Richard M Peek; Lauren R Teras; Kala Visvanathan; Yu Chen; Howard D Sesso; Anne Zeleniuch-Jacquotte; Sonja I Berndt; John D Potter; Marc D Ryser; Christopher A Haiman; Sylvia Wassertheil-Smoller; Lesley F Tinker; Tim Waterboer; Julia Butt
Journal:  Microorganisms       Date:  2020-10-30

4.  Helicobacter pylori infection with atrophic gastritis: An independent risk factor for colorectal adenomas.

Authors:  Qin-Fen Chen; Xiao-Dong Zhou; Dan-Hong Fang; En-Guang Zhang; Chun-Jing Lin; Xiao-Zhen Feng; Na Wang; Jian-Sheng Wu; Dan Wang; Wei-Hong Lin
Journal:  World J Gastroenterol       Date:  2020-10-07       Impact factor: 5.742

5.  Risk of subsequent prostate cancer in peptic ulcer patients who received helicobacter pylori eradication therapy: an Asian population-based cohort study.

Authors:  Chu-Wen Fang; Chun-Hao Chen; Chih-Hsin Muo; Shih-Chi Wu
Journal:  BMC Urol       Date:  2020-08-31       Impact factor: 2.264

6.  H. pylori Infection and Colorectal Cancers by Anatomical Locations.

Authors:  Dao Viet Hang; Dinh Thi Minh; Tran Hieu Hoc; Le Hong Phuoc; Tran Que Son; Ngoan Tran Le
Journal:  Asian Pac J Cancer Prev       Date:  2020-08-01

7.  Progress in elucidating the relationship between Helicobacter pylori infection and intestinal diseases.

Authors:  Shunji Fujimori
Journal:  World J Gastroenterol       Date:  2021-12-21       Impact factor: 5.742

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.